Res 0447-2026
Ensure insurance companies cover the cost of Preimplantation Genetic Testing for Aneuploidies.
ResolutionLaid OverCommittee on Healthintroduced 2026-04-30
Laid over — postponed to a later committee meeting.
Official record · Legistar
Agenda: 2026-04-30
Committee on Health — Department of Health and Mental Hygiene, Office of the Chief Medical Examiner and EMS (health-related issues).
Outlook
26% of similar bills passed
13 passed · 37 died
This bill: 73 days in committee
Similar bills: median 388 days · 70 days when passed
Compared against 50 Resolution bills in Committee on Health.
Ranked by how closely each matches this bill's topic — closest first:
Res 0201-2022
Establish full insurance coverage for fertility treatments.
577dFiled
Res 1433-2017
Amend the NYS insurance law to include the coverage of in vitro fertilization treatments. (A.528)
270dFiled
Res 0070-2018
Amend the NYS insurance law to include the coverage of in vitro fertilization treatments. (A.528)
1430dFiled
Res 0444-2014
Requiring insurance companies to cover other types of cancer screening testing including genetics testing, ultrasounds and magnetic resonance imaging.
1166dFiled
Res 0171-2022
Requiring that provision be made for pregnancy termination procedures in every individual or group policy or contract which provides coverage or indemnity for hospital, surgical or medical care and which offers maternity care coverage.
591dFiled
Res 0165-2024
Equity in Fertility Treatment Act (S.5545/A.885)
427dAdopted
+ 44 more comparable bills
Sponsors (6)
Lifecycle
IntroducedIntroduced by Council
2026-04-30 · City Council
ActionReferred to Comm by Council
2026-04-30 · City Council
HeardHearing Held by Committee
2026-06-15 · Committee on Health
HeardHearing Held by Committee
2026-06-15 · Committee on Hospitals
HeldLaid Over by Committee
2026-06-15 · Committee on Hospitals
HeldLaid Over by Committee
2026-06-15 · Committee on Health
HeardHearing Held by Committee
2026-06-15 · Committee on Disabilities
HeldLaid Over by Committee
2026-06-15 · Committee on Disabilities
Heard at (4)
Committee on Hospitals · 2026-06-15 · 10:00 AM · Council Chambers - City Hall
Committee on Health · 2026-06-15 · 10:00 AM · Council Chambers - City Hall
Committee on Disabilities · 2026-06-15 · 10:00 AM · Council Chambers - City Hall
City Council · 2026-04-30 · 1:30 PM · Council Chambers - City Hall
Attachments (6)
- Res. No. 447
- Memorandum in Support
- April 30, 2026 - Stated Meeting Agenda
- Hearing Transcript - Stated Meeting 4-30-26
- Committee Report 6/15/26
- Hearing Testimony 6/15/26
Full text
Res. No. 447
..Title
A resolution calling on the New York State Legislature to introduce and pass, and the Governor to sign, legislation to ensure insurance companies cover the cost of Preimplantation Genetic Testing for Aneuploidies
..Body
By Council Members Santosuosso, Louis, Hanif, Aldebol, Cab�n and Maloney
Whereas, Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a screening test that can be done while undertaking in vitro fertilization (IVF); and
Whereas, PGT-A is an optional IVF procedure that screens embryos for the correct number of chromosomes before transfer, therefore reducing risk of miscarriage by identifying chromosomes that may boost live birth rates, particularly in women over 35 years of age who have experienced recurrent pregnancy loss or repeated IVF failure in the past; and
Whereas, The process of PGT-A includes a biopsy of 5 to 10 embryos which are then frozen and sent for genetic analysis so that only embryos with the correct chromosome count are then selected for transfer, which may reduce the time and number of transfers required to achieve a successful pregnancy; and
Whereas, According to NYU Langone, for those without insurance, typical out of pocket costs for IVF procedures can run between $15,000 and $30,000 per cycle, while for those with insurance coverage, IVF out of pocket costs may drop to $1,500 to $6,000.00 per cycle; and
Whereas, To date, most insurance does not cover costs associated with the PGT-A procedure which is considered to be an "add on" or optional procedure; and
Whereas, According to the National Institutes of Health, PGT-A can cost an individual who is opting to undergo the additional screening an additional $3,000.00 to $6,000.00 per IVF cycle; and
Whereas, Ultimately the decision of whether or not to undergo PGT-A is a personal choice, and while there are potential benefits and drawbacks for each individual, the lack of inclusion of PGT-A as an integral part of the IVF treatment process rather than an additional expenditure should not pose a hinderance to help people achieve their dreams of parenthood; now, therefore be it
Resolved, That the Council of the City of New York calls on the New York State Legislature to introduce and pass, and the Governor to sign, legislation to ensure insurance companies cover the cost of Preimplantation Genetic Testing for Aneuploidies.
LS 21623
3/10/26
CD
2